VPS13A-related neurodegenerative disease

MONDO:0008695

A form of neuroacanthocytosis and is characterized clinically by a Huntington disease-like phenotype with progressive neurological symptoms including movement disorders, psychiatric manifestations and cognitive disturbances, and caused by a variation in the VPS13A gene.

Also known as: CHAC, Chac, Levine-Critchley syndrome, VPS13A disease, chorea-acanthocytosis, choreoacanthocytosis

18 clinical trials for this condition and its sub-types, 0 tagged with VPS13A-related neurodegenerative disease itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Hereditary skin disorder (885) ↑ Hereditary peripheral neuropathy (479) ↑ Epidermal disease (131) ↑ Neuroacanthocytosis (0)

Including sub-types (18) Tagged with VPS13A-related neurodegenerative disease (0)

Trials to join now! 14 Completed 3 Terminated 1

Could a simple blood test track nerve damage? a study investigates NT-3 levels in neuropathy.

Knowledge-focused Stopped early

This study measures levels of a protein called NT-3 in the blood of people with peripheral neuropathy or Charcot-Marie-Tooth disease. Researchers will compare these levels with measures of muscle strength, mobility, and daily function. The goal is to see whether NT-3 levels corre…

Sponsor: Zarife Sahenk • Aim: Knowledge-focused

Last updated Jul 31, 2026 00:00 UTC

VPS13A-related neurodegenerative disease

Where it sits in the disease tree

Could a simple blood test track nerve damage? a study investigates NT-3 levels in neuropathy.